Description
CJC-1295 DAC + Ipamorelin + GHRP-2 Triple Blend (6mg) research blend
CJC-1295 DAC + Ipamorelin + GHRP-2 Triple Blend combines a long-acting GHRH analogue (CJC-1295 with DAC) with two ghrelin-receptor agonists (Ipamorelin and GHRP-2) in one 6 mg vial.
Product details
| Compound | CJC-1295 with DAC, Ipamorelin and GHRP-2 |
|---|---|
| Class | Three-component GH secretagogue blend |
| Form | Peptides |
| Size | 6mg |
| Labelling | Compound name and strength on every container |
Select your format and strength from the options above.
What research has examined
- CJC-1295 with DAC: albumin-bound, long-acting GHRH receptor agonism.
- Ipamorelin and GHRP-2: ghrelin receptor (GHS-R1a) agonism with differing selectivity.
- Combination research: multi-receptor GH axis models.
Research interest does not establish a proven effect in humans.
Regulatory status
This compound is not an approved medicine. Growth hormone secretagogues and related peptides are prohibited in sport by WADA, and the material sold here is a research chemical only.
Storage and handling
Store lyophilised vials cold, dry and away from light. Reconstitute with a suitable sterile diluent under aseptic conditions and keep solutions refrigerated. See our peptide reconstitution guide.
Related research products
Ipamorelin + Epithalon + CJC-1295 No Dac Spray · CJC-1295 No DAC + Ipamorelin · Spartan 2 (Mod GRF 1-29/CJC-1295 No Dac + GHRP-2) · All peptides
References
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.
Reviews
There are no reviews yet.